0001209191-17-058477.txt : 20171031 0001209191-17-058477.hdr.sgml : 20171031 20171031181205 ACCESSION NUMBER: 0001209191-17-058477 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171031 FILED AS OF DATE: 20171031 DATE AS OF CHANGE: 20171031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 171166861 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-31 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CRO Common Stock 2017-10-31 4 S 0 900 142.40 D 89810 D Common Stock 2017-10-31 4 S 0 2800 143.49 D 87010 D Common Stock 2017-10-31 4 S 0 17362 144.47 D 69648 D Common Stock 2017-10-31 4 S 0 12438 145.26 D 57210 D Common Stock 2017-10-31 4 S 0 3200 146.53 D 54010 D Common Stock 2017-10-31 4 S 0 2200 147.70 D 51810 D Common Stock 2017-10-31 4 S 0 1000 148.35 D 50810 D Common Stock 2017-10-31 4 S 0 100 149.34 D 50710 D Common Stock 882 I 401(k) Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $142.40 (range $141.83 to $142.70). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $143.49 (range $142.87 to $143.85). Open market sales reported on this line occurred at a weighted average price of $144.47 (range $143.90 to $144.89). Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.93 to $145.87). Open market sales reported on this line occurred at a weighted average price of $146.53 (range $146.16 to $147.14). Open market sales reported on this line occurred at a weighted average price of $147.70 (range $147.18 to $148.15). Open market sales reported on this line occurred at a weighted average price of $148.35 (range $148.19 to $148.70). /s/ Omar White, Attorney-in-Fact 2017-10-31